M. Melchert

Management of RBC-transfusion dependence.

A. List, M. Melchert, Magda Melchert, 2007, Hematology. American Society of Hematology. Education Program.

Targeted therapies in myelodysplastic syndrome.

A. List, M. Melchert, Magda Melchert, 2008, Seminars in hematology.

A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy

J. Lancet, D. Rizzieri, A. List, 2015, American journal of hematology.

Managing acute myeloid leukemia in the elderly.

M. Melchert, 2006, Oncology.

Antiangiogenic Agents in Myeloid Malignancies

A. List, M. Melchert, Magda Melchert, 2008 .

The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes

A. List, Vishakha A Kale, M. Melchert, 2007, Current opinion in hematology.

Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome.

Scott E. Smith, J. Keck, J. Lancet, 2009, Blood.